RDGL Vivos Inc

$RDGL RDGL has some major catalysts lined up: • Mayo IRB submission and approval • Study activation • First U.S. patient dosed with RadioGel • 5-patient feasibility study results • Potential path to a pivotal study The FDA IDE is already approved. Mayo is on board and the protocol is finalized. At this share price, the upcoming milestones could get very interesting.

$RDGL RDGL at $0.0487 is only about a $24M market cap. That's the number investors should focus on. This isn't a company starting from zero. IsoPet: 200+ animal treatments. India: human clinical experience. PrecisionGel: continued platform development. FDA: IDE approved for the Mayo feasibility study. Now RDGL is moving toward the next major milestone: U.S. human treatment at Mayo. IRB ? First Patient ? Clinical Data ? Validation So look at where RDGL is today versus where the company is heading. A company with years of development, real-world IsoPet experience, international human experience, FDA authorization for U.S. clinical testing, and Mayo ahead is currently valued at only ~$24M. That's the disconnect. If Mayo produces positive clinical data, RDGL will have a very different set of facts for the market to value. At $0.0487, the current valuation looks extremely small relative to the milestones and potential ahead.

$RDGL for new investors this a great buy in. All of us older investors are just cranky lol

$RDGL Once this gets IRB approval, Mayo takes over. That approval, imo will be the start of the share price recovering from these ridiculous lows. First patient dosed and readout of the data from the 5 patients should move us much higher. Imo, the share price has been manipulated to get us at this present level. Bring on those trials,,,we know the science works as shown by ovewr 200 animal cases and positive resulots in the India study. Smart investors are taking advantage of the current share price.

$RDGL Holy crap bro. Seriously air out your iHub laundry on iHub! Again, this is not the iHub board! If you’re bullish this is no way to be bullish. You and are not helping the bulls on this board in the slightest. Just reading through your junk is irrelevant and irritating and just makes me want to sell Stick the the stock brothers!

$RDGL Is anyone talking about the 1 million Series D shares? The key wording is that each Series D holder is entitled to “the equivalent of fifty votes for every share of Common Stock issuable upon conversion” of their Series D. At the initial conversion price, $1.00 ÷ $0.08 = 12.5 common shares per Series D share. Therefore, 12.5 × 50 = 625 votes for each Series D share while it remains Series D. So 1 million Series D shares would indeed carry 625 million votes if all 1 million were issued and outstanding. If converted, those 1 million preferred shares would become 12.5 million common shares, which would carry 12.5 million ordinary common-stock votes. This is a huge voting control. Who are they doing this for? I feel like it's got to be someone important to give this kind of voting control.

$RDGL opinion on Nasdaq no rdgl would not get slaughtered on Nasdaq because they are operating like a big league company currently. If you look at the accomplishments on a shoestring budget CEO DR MIKE KORENKO has been lining things up for a Grand Slam. Hold on tight

$RDGL did anyone notice how they mentioned they are preparing to start human trials in Mexico? Crazy.

$RDGL What country are you from? You need to invest in a better translation app. Or atleast I hope it’s a bad app because you make zero sense bro and you’re not doing Vivos any favors.

$RDGL’s unnamed Mexican partner may be Mexico City’s National Cancer Institute (INCan), though Vivos hasn’t confirmed it. Its national referral role, nuclear medicine, radiation oncology and research capabilities make it a plausible fit. If confirmed, its infrastructure could support patient selection, image-guided injection, dosimetry and follow-up, potentially expanding RadioGel studies beyond thyroid cancer. Site readiness still needs verification. After November’s follow-up, an agreement and protocol could follow in Q1 2027. My earliest plausible first-treatment estimate is Q3 2027; Q4 is more realistic, subject to approvals, training, logistics and enrollment.

$RDGL lastly, MOM the team keeps buying into the company and increasing their own holdings. To me it’s quite indicative that they have faith in their own company’s growth.

$RDGL Properly investigated by the SEC, there's no iota of doubt in my mind you'll get put away for a very long time behind bars.

$RDGL LOL, major investor? Bring it on as you'll find when the arrangement is put up for shareholder vote. Like I previously stated, you're nothing but an amateur agent provocateur with the brain cells of a lizard. It is obvious from your arrogant, know-it-all content that you think you're some invincible genius. Vivos and its investors will be in agreement with real financiers who aren't out to fleece the company and its investors. Moving from crusading for rs NOW and at the worst price levels ( from a real investor of course) to scheming for a devious financier. I see your struggles and laugh at your schemes at trying to groom investors and shape sentiments. Your cover is already blown @ aka , , $$$, . Like a chameleon, there's a reason you're constantly changing your handles and opening new accounts in efforts at covering your tracks and devious intents.

$RDGL Big fat LOL at your funny post. People of your mindset are exactly the problem in the market. Naturally as humans, our individual views and perception will most always differ but some core values are fundamental IMO. Unlike some with an OTC mentality (including the willingness to say anything however false in the pursuit of money or profits), I'll always call a spade a spade. I don't put money in any ticker based on group mentality; neither do I seek validation from you or anyone. However, trolls and sketchy characters infestation on the message boards cannot be allowed to fester without being countered with opposing view points which is what some people on there don't want. They just like the appearance of impartiality; not the actual existence of it. Too much double standards in the application of board rules. Overbearing censorship on the daily that is poisonous to mutual exchange of view points. FYI, I wasn't banned; just 3 months biased suspension.

$RDGL if you read the stock boards lots of deceiving posters ...have no clue whats actually happening with RDGL behind the scenes. Its all speculation that amounts to a hill of kidney beans lol You would think they would at least have a coffee bean in the mornings. One day they will wakeup to incredible news. Its coming.

$RDGL CEO knew the company potential huge purchase at .50c check out $TIPS ceo just sold $NXGB and cancel 2N shares

$RDGL where in the world is an update on moving forward with an EFS, the goalposts always move for human therapy and it’s the same non sense everytime… smh

$RDGL I challenge anyone to present a negative detail about Radiogel/Isopet as it pertains to cancer treatment. Specifically the technology, not the company (Vivos, Inc.) per se. So what is the downside? IDE - The program ensures that as RadioGel progresses through its active trials at the Mayo Clinic, the resulting data will be reviewed far faster than a standard oncology device, though its eventual approval remains completely dependent on positive trial results. With the data from India, it would suggest anything other than positive results from the Mayo Clinic is manipulation. However the “pause” looks suspiciously like manipulation, as it essentially synchronizes the U.S. /India trials. Big Pharma has deep pockets, and it’s painfully obvious they like to control the “oncology industry”, among some of the other specialties.

$RDGL Nothing to say is there when you review Vivos (rdgl) website its very clear. Now we wait.

$RDGL for those who think the FDA only approved the IDE with “conditions” and did not approve with full “standard” approval, think again. Don’t listen to the bashers and manipulators who are trying to screw you and with their attempts to manipulate and slander this stock ….